As virtual healthcare continues to grow in popularity, women’s health company Allara Health has recently secured $26 million in Series B funding to further revolutionize care for women battling chronic hormonal conditions. This funding will enable the company to expand its reach and provide personalized treatment options to women nationwide.
Allara Health, based in New York City, specializes in helping women with conditions such as polycystic ovarian syndrome, endometriosis, and hypothyroidism. Patients receive comprehensive care through video consultations with OBGYNs, nurse practitioners, and registered dietitians, as well as personalized care plans that include nutritional recommendations, lifestyle changes, and medication if necessary. The company accepts insurance plans from major providers like UnitedHealthcare, Aetna, and Cigna.
According to Martin Mignot, partner at Index Ventures, women have historically been overlooked in healthcare, and Allara Health’s approach offers a new way for women to access specialty care. With the support of leading investors like Index Ventures and Google Ventures, Allara Health has now raised a total of $38.5 million to expand its services and reach more women in need.
FAQs
Q: What services does Allara Health offer?
A: Allara Health provides personalized care for women battling chronic hormonal conditions, including video consultations, hormonal and metabolic testing, personalized care plans, nutritional recommendations, and ongoing support from healthcare professionals.
Q: Does Allara Health accept insurance?
A: Yes, Allara Health accepts insurance plans from major providers such as UnitedHealthcare, Aetna, and Cigna.
Q: How can women access care from Allara Health?
A: Women can start by scheduling a video consultation with an OBGYN or nurse practitioner through Allara Health’s website.
In addition to Allara Health, there are other digital health companies like WellTheory and Visana Health that are also focused on providing care for women with hormonal conditions. These companies are helping to address the significant challenges faced by women in accessing timely diagnosis and treatment for hormonal conditions.
In conclusion, the $26 million in Series B funding secured by Allara Health reflects a growing recognition of the need for specialized care for women with chronic hormonal conditions. By expanding its reach and enhancing its services, Allara Health is paving the way for improved access to quality healthcare for women nationwide.